Table 3 Summary of HR for PFS by Age
From: Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Age | HR (95% CI) |
|---|---|
Age < 65 years | 0.73 (0.61 to 0.88) |
Age ≥ 65 years | 0.74 (0.60 to 0.92) |
From: Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Age | HR (95% CI) |
|---|---|
Age < 65 years | 0.73 (0.61 to 0.88) |
Age ≥ 65 years | 0.74 (0.60 to 0.92) |